Last reviewed · How we verify
NCT07321314
RSV Burden in Hong Kong
trial testing Serial specimen sampling in RSV in 10,000 participants. Not yet recruiting.
29 February 2028
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 10,000 |
| Start date | 1 March 2026 |
| Primary completion | 29 February 2028 |
| Estimated completion | 31 August 2028 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Serial specimen sampling
Conditions studied
- RSV — all drugs for RSV →
Sponsor
Chinese University of Hong Kong
Who can join
18 and older, any sex, with RSV. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
RSV infection causes significant mortality and morbidity in susceptible adults. There are many publications on the global RSV disease burden in infants and young children but data on adults are lacking with lots of knowledge gaps. Currently there is no established effective antiviral therapy for RSV. RSV vaccines have recently become available commercially but the Center for Health Protection (Hong Kong) has yet to discuss procurement of RSV vaccines for the high risk groups. Thus a prospective study to assess the disease burden of RSV infection in adults would be of great interest.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07321314
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for RSV
Currently open trials in the same condition.
- NCT07147517 — Preparedness Through Respiratory Virus Epidemiology and Community Engagement · recruiting
- NCT06511687 — Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL) · recruiting
- NCT06160128 — Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA) · recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07321314 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07321314.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing